Inception Return
(6/10/2013)
|
6.20 %
|
|
YTD Return
|
2.93 %
|
|
NAVPS
(12/5/2023)
|
$14.02
|
|
Change
|
$0.01 / 0.06 %
|
|
|
Growth of $10,000
(As of October 31, 2023)
|
|
MER
|
1.99 %
|
|
Assets ($mil)
|
$346.90
|
|
Rank (1Yr)
|
574/1690
|
|
Std Dev (3Yr)
|
10.29 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
Front Fee Only
|
|
Max Front End
|
5.00 %
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The fundamental investment objective of the Pool is to seek to generate income and capital appreciation primarily through exposure to a diversified portfolio primarily consisting of dividend paying equity and fixed income securities. The Pool will also invest its assets in equity, fixed income, mutual fund or exchange-traded fund securities.
|
Fund Manager
Manulife Investment Management Limited
Portfolio Manager
Manulife Investment Management Limited
Sub-Advisor
Michael J. Mattioli, Manulife Investment Management (US) LLC
Daniel S. Janis III, Manulife Investment Management (US) LLC
Thomas C. Goggins, Manulife Investment Management (US) LLC
Sandy Sanders, Manulife Investment Management (US) LLC
|
|
Asset Allocation
(As of September 30, 2023)
|
Sector Allocation
(As of September 30, 2023)
|
Geographic Allocation
(As of September 30, 2023)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Manulife Global Fixed Income Private Trust Adv | Foreign Bonds | Fixed Income | Multi-National | 0.00% |
| Crown Castle International Corp | US Equity | Real Estate | United States | 0.00% |
| KKR & Co Inc | US Equity | Financial Services | United States | 0.00% |
| US Dollar | Cash and Equivalents | Cash and Cash Equivalent | United States | 0.00% |
| Apple Inc | US Equity | Technology | United States | 0.00% |
| American Tower Corp | US Equity | Real Estate | United States | 0.00% |
| Cellnex Telecom SA | International Equity | Telecommunications | European Union | 0.00% |
| Anthem Inc | US Equity | Healthcare | United States | 0.00% |
| GSK plc - ADR | International Equity | Healthcare | European Union | 0.00% |
| Moderna Inc | US Equity | Healthcare | United States | 0.00% |
Performance Data
(As of October 31, 2023)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
-1.40
|
-5.30
|
-3.41
|
2.93
|
4.58
|
4.75
|
4.39
|
5.96
|
|
Benchmark
|
0.21
|
-2.95
|
-2.10
|
4.24
|
8.02
|
1.35
|
4.50
|
6.61
|
|
Quartile Ranking
|
4
|
4
|
2
|
1
|
2
|
1
|
2
|
1
|
|
Calendar Return (%)
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|
Fund
|
-9.74
|
13.63
|
4.28
|
19.93
|
-9.83
|
9.79
|
9.31
|
5.29
|
13.35
|
-
|
|
Benchmark
|
-11.62
|
6.48
|
11.12
|
12.26
|
2.68
|
8.66
|
2.39
|
17.05
|
12.44
|
18.86
|
|
Quartile Ranking
|
2
|
1
|
4
|
1
|
4
|
1
|
1
|
2
|
1
|
-
|